Common Stock, Shares, Outstanding of GALECTIN THERAPEUTICS INC from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
GALECTIN THERAPEUTICS INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • GALECTIN THERAPEUTICS INC Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 64,472,792, a 3.5% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

GALECTIN THERAPEUTICS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 64,472,792 +2,164,717 +3.5% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 64,060,262 +1,782,137 +2.9% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 63,291,585 +1,143,451 +1.8% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 63,157,235 +1,304,321 +2.1% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 62,308,075 +459,418 +0.74% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 62,278,125 +2,695,872 +4.5% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 62,148,134 +2,565,881 +4.3% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 61,852,914 +2,426,909 +4.1% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 61,848,657 +2,422,652 +4.1% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 59,582,253 +186,448 +0.31% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 59,582,253 +193,735 +0.33% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 59,426,005 +84,700 +0.14% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 59,426,005 +84,700 +0.14% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 59,395,805 +120,774 +0.2% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 59,388,518 +2,201,863 +3.8% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 59,341,305 +2,264,250 +4% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 59,341,305 +2,264,250 +4% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 59,275,031 +2,380,389 +4.2% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 57,186,655 +292,013 +0.51% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 57,077,055 +182,413 +0.32% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 57,077,055 +418,196 +0.74% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 56,894,642 +303,364 +0.54% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 56,894,642 +11,300,231 +25% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 56,894,642 +15,703,737 +38% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 56,658,859 +15,522,121 +38% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 56,591,278 +15,963,095 +39% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 45,594,411 +7,948,440 +21% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 41,190,905 +5,401,517 +15% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 41,136,738 +5,498,040 +15% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 40,628,183 +5,662,394 +16% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 37,645,971 +2,975,287 +8.6% 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 35,789,388 +2,876,446 +8.7% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 35,638,698 +6,242,079 +21% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 34,965,789 +5,685,136 +19% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 34,670,684 +5,691,505 +20% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 32,912,942 +4,087,909 +14% 31 Dec 2016 10-K 29 Mar 2018 2017 FY
Q3 2016 29,396,619 +5,467,375 +23% 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 29,280,653 +5,491,740 +23% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 28,979,179 +5,249,294 +22% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 28,825,033 +6,547,750 +29% 31 Dec 2015 10-K 28 Mar 2017 2016 FY
Q3 2015 23,929,244 +1,805,661 +8.2% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 23,788,913 +1,754,121 +8% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 23,729,885 +1,823,713 +8.3% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 22,277,283 +3,890,383 +21% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 22,123,583 +4,472,606 +25% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 22,034,792 +5,735,165 +35% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 21,906,172 +5,715,743 +35% 31 Mar 2014 10-Q 13 May 2014 2014 Q1
Q4 2013 18,386,900 +2,326,047 +14% 31 Dec 2013 10-K 18 Mar 2015 2014 FY
Q3 2013 17,650,977 +1,684,540 +11% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 16,299,627 +480,281 +3% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 16,190,429 +519,817 +3.3% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 16,060,853 +3,141,315 +24% 31 Dec 2012 10-K 21 Mar 2014 2013 FY
Q3 2012 15,966,437 -60,941,003 -79% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 15,819,346 -58,237,523 -79% 30 Jun 2012 10-Q 10 Aug 2012 2012 Q2
Q1 2012 15,670,612 31 Mar 2012 10-Q 11 May 2012 2012 Q1
Q4 2011 12,919,538 +2,268,003 +21% 31 Dec 2011 10-K 29 Mar 2013 2012 FY
Q3 2011 76,907,440 30 Sep 2011 10-Q 10 Nov 2011 2011 Q3
Q2 2011 74,056,869 30 Jun 2011 10-Q 12 Aug 2011 2011 Q2
Q4 2010 10,651,535 31 Dec 2010 10-K 30 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.